Wellcome Trust Sanger Institute Promotes Mike Stratton to Director | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Mike Stratton has been named the new director of the Wellcome Trust Sanger Institute, where he has served as deputy director since 2007.

Stratton has been acting director of the institute's Board of Management since March, when Allan Bradley stepped down as director after 10 years at the institute's helm in order to found a startup company and focus on his research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.